Ansøgningsnr. og dato | 18815293.8 (espacenet) (Federated) (European Patent Register), 20181128 | Patent/reg.nr. og dato | DK/EP 3716952, 20220105 | Tilgængelighedsdato | 20201007 | Prioritetsnr. og dato | US 201762592242 P, 20171129, GB 201721515, 20171221 | EP publ. nr. og dato |
EP 3716952 20201007 | Løbedag | | Ansøger/indehaver | Kalvista Pharmaceuticals Limited, Porton Science Park Bybrook Road Porton Down, Salisbury SP4 0BF Wiltshire, GB | Ansøgers ref. nr. | P79056DK01 | Opfinder | COLLETT, John Herman, Quay Pharmaceuticals Ltd. 28 Parkway Deeside Industrial Park
Deeside Flintshire CH5 2NS, GB, COOK, Gary Paul, 66 Griffin Road
Westford Massachusetts 01886, US, FARRAR, Jamie Joseph, Quay Pharmaceuticals Ltd. 28 Parkway Deeside Industrial Park
Deeside Flintshire CH5 2NS, GB, FRODSHAM, Michael John, Quay Pharmaceuticals Ltd. 28 Parkway Deeside Industrial Park
Deeside Flintshire CH5 2NS, GB, ROE, Michael Bryan, Kalvista Pharmaceutical Limited Porton Science Park Bybrook Road
Porton Down Wiltshire SP4 0BF, GB, TODD, Richard Simon, Kalvista Pharmaceuticals Limited Porton Science Park Bybrook Road
Porton Down Wiltshire SP4 0BF, GB, WARD, Robert Neil, Quay Pharmaceuticals Ltd. 28 Parkway Deeside Industrial Estate
Deeside Flinshire CH5 2NS, GB | Fuldmægtig | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Interessent på tilknyttet sag | | IPC-Klasse | A61K 31/00 (2006.01) , A61K 31/444 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61K 9/48 (2006.01) | Titel/benævnelse | DOSERINGSFORMER OMFATTENDE EN PLASMAKALLIKREIN-INHIBITOR | Internationalt ansøgningsnr. | GB2018053443 | Internationalt publ. nr. | WO2019106361 | Relateret sag (certifikat) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|